Spread the love

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, MiRNA-based therapy for Cancer: MIRNA-134  decreases the expression of immortality-associated gene product telomerase via down regulation of its target gene, 22/September/2014, 08.49 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Significance: This study suggests that MIRNA-134 inhibits the expression of immortality gene telomerase. Thus, pharmacological formulations encompassing MIRNA-134 or MiRNA-134 activators” may be used to inhibit cancer progression.  Further, pharmacological formulations encompassing “AntagomiR-134 or MiRNA-134 inhibitors” may be used to (1) deaccelerate ageing/senescence process; and (2) increase the longevity of an individual.

* Research cooperation

Spread the love